Philips Acquires Spectrawave to Boost AI-Assisted Cardiovascular Diagnostics
Photo by Craig Cameron on Unsplash
On December 15, 2025, Philips acquired Spectrawave, a U.S. company based in Bedford, Massachusetts, that specializes in AI-assisted intravascular imaging technology for heart conditions, and employs over 70 individuals. The deal incorporates Spectrawave's Hypervue and X1-FFR systems, which use OCT, NIRS, and AI to enhance diagnostic capabilities for cardiovascular disease.
Key takeaways
- According to Medtech Magazine, Philips announced the acquisition of Spectrawave, a U
- -based company specializing in AI-assisted intravascular imaging for cardiovascular disease, on December 15, 2025
- The acquisition will integrate Spectrawave's Hypervue and X1-FFR systems, which utilize a combination of optical coherence tomography (OCT), near-infrared spectroscopy (NIRS), and artificial intelligence (AI) to improve diagnostic accuracy
Related Topics
Want coverage like this for your company?
Local & industry wins build trusted proof, SEO/geo signals and prime national editors.
Check fit (2 min)Is this your company?
Set up real-time alerts and keep your Heartspace News coverage accurate. Verified teams can update profiles, request corrections, and collaborate on future stories.
Want to turn mentions into momentum? Find your best path with the Fit Checker. Verified profiles receive a free consult.